Real World Effectiveness of Golimumab Therapy in Ulcerative Colitis Regardless of Prior TNF Exposure.
Journal of the Canadian Association of Gastroenterology(2018)
摘要
Overall, the persistence rate of golimumab observed in the current real-world study is similar to that described in previous single-centre UC cohorts and consistent with that seen in controlled clinical trials.
更多查看译文
关键词
Biologics,Compliance/adherence,Inflammatory bowel disease,Ulcerative colitis
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要